(Total Views: 586)
Posted On: 06/16/2022 1:18:56 PM
Post# of 148903
AKRO touting its NASH deal with Pfizer, which took a 6.7% stake in the company. They are claiming they are "best in class" for NASH -- uh, um, as of 2020, just yesterday, huh? And whoopee, their drug seems to prevent FURTHER liver scarring.
I'm underwhelmed. But this is what we have to deal with -- CYDY has a drug that reduces fibrosis, and people like AF and the short cartel attack the company. These jokers have something that hopefully will help some people to avoid getting worse, but that doesn't improve their condition -- and they're the Second Coming because Pfizer likes them.
https://endpts.com/nash-focused-akero-therape...zers-help/
I'm underwhelmed. But this is what we have to deal with -- CYDY has a drug that reduces fibrosis, and people like AF and the short cartel attack the company. These jokers have something that hopefully will help some people to avoid getting worse, but that doesn't improve their condition -- and they're the Second Coming because Pfizer likes them.
https://endpts.com/nash-focused-akero-therape...zers-help/
(2)
(0)Scroll down for more posts ▼
